Capricor Therapeutics Stock Forecast
Capricor Therapeutics stock price down 1.69% on Thursday
(Updated on May 02, 2024)
The Capricor Therapeutics stock price fell by -1.69% on the last day (Thursday, 2nd May 2024) from $5.33 to $5.24. During the last trading day the stock fluctuated 3.95% from a day low at $5.20 to a day high of $5.40. The price has fallen in 6 of the last 10 days but is still up by 3.76% over the past 2 weeks. Volume has increased on the last day by 39 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 210 thousand shares were bought and sold for approximately $1.10 million.
The stock lies in the lower part of a very wide and strong rising trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $5.07 is broken, it will firstly indicate a slower rate of rising, but may also be an early warning for a trend shift. Given the current short-term trend, the stock is expected to rise 38.26% during the next 3 months and, with a 90% probability hold a price between $7.01 and $10.95 at the end of this 3-month period.
Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.
CAPR Signals & Forecast
There are few to no technical positive signals at the moment. The Capricor Therapeutics stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $5.25 and $6.08. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Monday, April 01, 2024, and so far it has fallen -26.15%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Capricor Therapeutics gained volume on the last day, but on falling prices. In technical terms, this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-offs".
Support, Risk & Stop-loss for Capricor Therapeutics stock
Capricor Therapeutics finds support from accumulated volume at $5.05 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.205 between high and low, or 3.95%. For the last week, the stock has had daily average volatility of 5.80%.
Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.
Trading Expectations (CAPR) For The Upcoming Trading Day Of Friday 3rd
For the upcoming trading day on Friday, 3rd we expect Capricor Therapeutics to open at $5.28, and during the day (based on 14 day Average True Range), to move between $4.83 and $5.65, which gives a possible trading interval of +/-$0.412 (+/-7.86%) up or down from last closing price. If Capricor Therapeutics takes out the full calculated possible swing range there will be an estimated 15.72% move between the lowest and the highest trading price during the day.
Since the stock is closer to the support from accumulated volume at $5.05 (3.63%) than the resistance at $5.80 (10.69%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..
Earnings coming up
Capricor Therapeutics will release earnings BMO on Thursday, May 09, 2024.The consensus among the analysts for the expected earnings (EPS) is -$0.110. We will update the financials statements for Capricor Therapeutics, that can be found here as soon as the records are public. Our systems has calculated a possible swing of +/- 9.41% in the first trading day after earnings release.
Is Capricor Therapeutics stock A Buy?
The Capricor Therapeutics stock holds several negative signals and despite the positive trend, we believe Capricor Therapeutics will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.
Current score: -2.872 Sell Candidate Unchanged
Predicted Opening Price for Capricor Therapeutics of Friday, May 3, 2024
| Fair opening price May 3, 2024 | Current price |
|---|---|
| $5.28 ( 0.732%) | $5.24 |
The predicted opening price is based on yesterday's movements between high, low, and closing price.
Trading levels for CAPR
Fibonacci Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 5.48 | 4.64 % | |
| R2 | 5.41 | 3.15 % | ||
| R1 | 5.36 | 2.23 % | ||
| Current price: | 5.24 | |||
| Support | S1 | 5.20 | -0.763 % | |
| S2 | 5.15 | -1.69 % | ||
| S3 | 5.07 | -3.18 % |
Accumulated Volume Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 6.38 | 21.76 % | |
| R2 | 5.89 | 12.40 % | ||
| R1 | 5.80 | 10.69 % | ||
| Current price | 5.24 | |||
| Support | S1 | 5.05 | -3.63% | |
| S2 | 5.04 | -3.82% | ||
| S3 | 4.82 | -8.02% |
FAQ
Click here for our free guide on how to buy Capricor Therapeutics Stock.
